CareRx Corporation (TSX:CRRX) Renews NCIB to Repurchase Up to 1.75M Shares
CareRx received TSX approval for a normal course issuer bid to buy back up to 1,750,000 shares (about 2.75% of outstanding) from Sep 17, 2026 to Sep 16, 2027, with a daily limit of 7,105 shares per TSX rules.Material DetailsContext by AI AnalystThis extends a capital return program after a smaller…